Impact of double-j ureteric stent in kidney transplantation: single-center experience.
We retrospectively evaluated the use of double-j stent and the incidence of urological complications in 2 groups of patients who received a kidney transplant. From January 2005 to September 2007 we studied 172 patients receiving kidney transplants, 65 and 107 from living and cadaver donors, respectively. From the 172 patients, a total of 34 were excluded due to ureterostomy or Politano-Leadbetter ureterovesical anastomosis. Another 21 patients were excluded from the study due to graft loss due to acute or hyperacute rejection, cytomegalovirus (CMV) infection, or vascular complication. The remaining patients were divided into 2 groups: group A (44 patients) and B (73 patients) with versus without the use of a double-j-stent, respectively. The 2 groups were comparable in terms of donor and recipient gender, ischemia time, and delayed graft function. We failed to observes significant differences between the 2 groups in mean hospital stay (23 +/- 9 and 19 +/- 9), urinary leak (2.3% and 4.1%), and urinary tract infection (20.4% and 19.2%), among groups A and B, respectively. The only difference observed concerned the gravity of the urinary leak; no surgical intervention was needed among the double-j stent group versus 2 patients demanding ureterovesical reconstruction in the nonstent group. In conclusion, our data suggested that the routine use of a double-j stent for ureterovesical anastomosis neither significantly increased urinary tract infection rates, nor decreased the incidence of urinary leaks, but may decrease the gravity of the latter as evidenced by the need for surgical intervention.
Giakoustidis
D
D
Department of Transplant Surgery, School of Medicine, Aristotle University, Hippokration Hospital, Thessaloniki, Greece. dgiak@auth.gr
Diplaris
K
K
Antoniadis
N
N
Papagianis
A
A
Ouzounidis
N
N
Fouzas
I
I
Vrochides
D
D
Kardasis
D
D
Tsoulfas
G
G
Giakoustidis
A
A
Miserlis
G
G
Imvrios
G
G
Papanikolaou
V
V
Takoudas
D
D
D004867:Equipment Design; D006085:Graft Survival; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000401:mortality; D018579:Patient Selection; D012189:Retrospective Studies; D015607:Stents; D016019:Survival Analysis; D017741:Survivors; D014515:Ureteral Diseases / Q000209:etiology* / Q000601:surgery*; D014519:Ureterostomy